Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2012
On discounting of health gains from human papillomavirus vaccination: effects of different approaches
Tjalke A Westra, Mehraj Parouty, Werner B Brouwer, et al.
Scientific Reports
|
January 4, 2025
Oncolytic alphavirus-induced extracellular vesicles counteract the immunosuppressive effect of melanoma-derived extracellular vesicles
Darshak K Bhatt, Annemarie Boerma, Silvina Odete Bustos, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 1, 2019
GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles
Annelies Jorritsma-Smit, Coba J van Zanten, Jolande Schoemaker, et al.
BMC Public Health
|
July 7, 2018
Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study
Robine Donken, Adriana Tami, Mirjam J Knol, et al.
Oncoimmunology
|
September 22, 2017
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
Fenne L Komdeur, Thalina M Prins, Stephanie van de Wall, et al.
Clinical & Developmental Immunology
|
October 2, 2010
Potential target antigens for a universal vaccine in epithelial ovarian cancer
Renee Vermeij, Toos Daemen, Geertruida H de Bock, et al.
Gynecologic Oncology
|
February 27, 2009
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer
Ninke Leffers, Marloes J M Gooden, Anna A Mokhova, et al.
BMC Public Health
|
April 1, 2014
Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands
Madelief Mollers, Karin Lubbers, Symen K Spoelstra, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 10, 2011
Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression
Renee Vermeij, Geertruida H de Bock, Ninke Leffers, et al.
Cancer Immunology, Immunotherapy : CII
|
September 16, 2008
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
Ninke Leffers, Marloes J M Gooden, Renske A de Jong, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 16, 2012
On discounting of health gains from human papillomavirus vaccination: effects of different approaches
Tjalke A Westra, Mehraj Parouty, Werner B Brouwer, et al.
Scientific Reports
|
January 4, 2025
Oncolytic alphavirus-induced extracellular vesicles counteract the immunosuppressive effect of melanoma-derived extracellular vesicles
Darshak K Bhatt, Annemarie Boerma, Silvina Odete Bustos, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
November 1, 2019
GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles
Annelies Jorritsma-Smit, Coba J van Zanten, Jolande Schoemaker, et al.
BMC Public Health
|
July 7, 2018
Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study
Robine Donken, Adriana Tami, Mirjam J Knol, et al.
Oncoimmunology
|
September 22, 2017
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer
Fenne L Komdeur, Thalina M Prins, Stephanie van de Wall, et al.
Clinical & Developmental Immunology
|
October 2, 2010
Potential target antigens for a universal vaccine in epithelial ovarian cancer
Renee Vermeij, Toos Daemen, Geertruida H de Bock, et al.
Gynecologic Oncology
|
February 27, 2009
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer
Ninke Leffers, Marloes J M Gooden, Anna A Mokhova, et al.
BMC Public Health
|
April 1, 2014
Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands
Madelief Mollers, Karin Lubbers, Symen K Spoelstra, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
June 10, 2011
Tumor-infiltrating cytotoxic T lymphocytes as independent prognostic factor in epithelial ovarian cancer with wilms tumor protein 1 overexpression
Renee Vermeij, Geertruida H de Bock, Ninke Leffers, et al.
Cancer Immunology, Immunotherapy : CII
|
September 16, 2008
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
Ninke Leffers, Marloes J M Gooden, Renske A de Jong, et al.
Page
of 9